Sort by
Refine Your Search
-
patient-specific human induced pluripotent stem cells (iPSCs), primary human cells/tissues, along with animal models, to develop a platform for the evaluation of cardiovascular toxicity associated with
-
use a combination of patient-specific human induced pluripotent stem cells (iPSCs), primary human cells/tissues, along with animal models, to develop a platform for the evaluation of cardiovascular
-
progression and metastasis, and the combination of radiation treatment with immune checkpoint inhibitors in anti-cancer therapy. The positions will involve the use of animal models, human cell lines, and
-
models, human tissue and blood samples. Use biochemical, cellular, molecular, and pharmacological approaches to for mechanistic studies. Use cutting-edge technologies for transcriptomic, proteomic, and